Schimmer O, Häfele F, Krüger A
Institut für Botanik und Pharmazeutische Biologie, Universität Erlangen-Nürnberg, F.R.G.
Mutat Res. 1988 Oct;206(2):201-8. doi: 10.1016/0165-1218(88)90161-9.
Four commercial ethanolic plant extracts, Tinctura Alchemillae, Extractum Crataegi, Extractum Myrtilli and Tinctura Hyperici, were tested for their mutagenicity in Salmonella typhimurium TA98 and TA100 with and without S9 mix obtained from rats pretreated with phenobarbital. The extracts studied differed greatly in their mutagenic potencies but exhibited a very similar mutation pattern in which the strongest effect was always seen in tester strain TA98 with S9 mix. Simultaneously we investigated the extracts for the presence of quercetin and kaempferol. Only quercetin was detected in small amounts by thin-layer chromatography (TLC). The fractions containing quercetin were separated and collected using a Sephadex LH-20 column. Two different methods were employed to estimate the amount of quercetin in the extracts: a colorimetric assay developed by Christ and Müller, and a complexometric method by Belikov. The quercetin concentrations ranged between 2 mg (Tinctura Alchemilla) and 89 mg (Tinctura Hyperici) per 100 g of extract. We suggest that the mutagenicity of the 4 plant extracts is mainly due to the presence of quercetin for the following reasons: (1) all the plant extracts exhibit a mutation pattern which is very similar to that of quercetin, (2) the mutagenic potential of the extracts correlates well with their quercetin content, considering the fact that plant extracts are very complex mixtures often containing toxic or antimutagenic compounds.
对四种市售植物乙醇提取物,即绵马酊、山楂提取物、越橘提取物和金丝桃酊,在有和没有经苯巴比妥预处理的大鼠肝脏制备的S9混合液存在的情况下,检测它们在鼠伤寒沙门氏菌TA98和TA100菌株中的致突变性。所研究的提取物在致突变能力上差异很大,但表现出非常相似的突变模式,其中在有S9混合液存在时,在测试菌株TA98中总是观察到最强的效应。同时,我们研究了这些提取物中槲皮素和山奈酚的存在情况。通过薄层色谱法(TLC)仅检测到少量的槲皮素。使用葡聚糖凝胶LH - 20柱分离并收集含有槲皮素的馏分。采用两种不同方法来估计提取物中槲皮素的含量:一种是由克里斯特和米勒开发的比色法,另一种是贝利科夫的络合滴定法。槲皮素浓度范围为每100克提取物中2毫克(绵马酊)至89毫克(金丝桃酊)。基于以下原因,我们认为这4种植物提取物的致突变性主要归因于槲皮素的存在:(1)所有植物提取物都呈现出与槲皮素非常相似的突变模式;(2)考虑到植物提取物是非常复杂的混合物,通常含有有毒或抗突变化合物,提取物的致突变潜力与其槲皮素含量密切相关。